| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 11/25/2009 | CN101584674A Venlafaxine hydrochloride sustained-release tablet preparation and preparation method thereof |
| 11/25/2009 | CN101584673A Levetiracetam tablet and preparation method |
| 11/25/2009 | CN101584672A Clofarabine pharmaceutical composition freeze-dried powder injection and preparation method thereof |
| 11/25/2009 | CN101584669A Melphalan freeze-dried powder injection |
| 11/25/2009 | CN101584667A Biodegradation type long-acting contraception microsphere and preparation method and application thereof |
| 11/25/2009 | CN101584666A Preparing method of proton pump inhibitor biological adhesive preparation |
| 11/25/2009 | CN101584665A Cefotiam hydrochloride medicament composition sterile powder injection and preparation method thereof |
| 11/25/2009 | CN101584664A Cefodizime sodium proliposome preparation and preparation method thereof |
| 11/25/2009 | CN101584663A Novel delivery system of Duoxitasai lipidosome for injection and preparation method thereof |
| 11/25/2009 | CN101584662A Etoposide lipidosome and preparation method thereof |
| 11/25/2009 | CN101584661A Preparation of sorafenib self-microemulsifying drug delivery system for oral administration or intravenous injection and use thereof |
| 11/25/2009 | CN101584659A Docetaxel medicament composition injection and preparation method thereof |
| 11/25/2009 | CN101584658A Preparation method of amikacin sulfate injection |
| 11/25/2009 | CN101584657A Tilmicosin solution and preparation method thereof |
| 11/25/2009 | CN101584653A Stable suppository containing roxithromycin |
| 11/25/2009 | CN101584652A Risperidone sustained-release gel injection and preparation method thereof |
| 11/25/2009 | CN100562341C Application of cell nucleus targeting chitosan-fatty acid graft as medicine carrier micelle |
| 11/25/2009 | CN100562340C A micro-emulsion type artificial tear |
| 11/25/2009 | CN100562338C Beta-amyloid-analogue-cell epitop vaccine |
| 11/25/2009 | CN100562329C Decompression unction composition and method for producing same |
| 11/25/2009 | CN100562327C Health-care food for improving sleeping and its preparing process |
| 11/25/2009 | CN100562317C Granules containing acid-unstable chemical in large amount |
| 11/25/2009 | CN100562311C Cisplatin preparation method and its application method |
| 11/25/2009 | CN100562309C Injectable composition of clopidogrel and its salt and preparation method thereof |
| 11/24/2009 | US7622556 Modified cytokines for use in cancer therapy |
| 11/24/2009 | US7622530 Biocompatible block copolymer comprising one or more elastomeric blocks and one or more thermoplastic blocks connected by a seed polymer |
| 11/24/2009 | US7622459 alkaline deproteination and subsequent elimination of water-soluble components consists in that the so obtained insoluble glucan is subsequently hydrated by wet grinding; heat sterilizing, results in a fungal polysaccharide with the beta -(1,3)-D-bond in the principal chain |
| 11/24/2009 | US7622446 Polypeptides, derivatives and uses thereof |
| 11/24/2009 | US7622441 Comprising controlled substance and amino acid or polypeptide covalently bound to controlled substance in manner that renders controlled substance pharmacologically inactive; when delivered by oral route controlled substance is released in time-dependent manner by acid hydrolysis and/or enzyme cleavage |
| 11/24/2009 | US7622280 Silicone based surfactant comprising hydrophobic and hydrophilic phases containing functional in vitro eukaryotic expression systems; compartmentalisation of transcription/translation reactions |
| 11/24/2009 | US7622277 suitable as carriers for drugs used for the treatment of diseases of the central nervous system; can penetrate the blood-brain barrier |
| 11/24/2009 | US7622138 gel comprising glycerol formal solvent, hydroxypropyl methylcellulose and a dissolved antibacterial agent Tobramycin, antifungal agent Terbinafine , and a steroid Betamethasone; controlled- or sustained-release; treating microbial infection of the skin, ear, or eye, especially for veterinary application |
| 11/24/2009 | US7622128 Porphyromonas gingivalis 1435/1449 LPS as an immune modulator |
| 11/24/2009 | US7622127 Clostridial toxin derivatives and methods for treating pain |
| 11/24/2009 | US7622121 Heat shock proteins from Mycobacterium leprae and uses thereof |
| 11/24/2009 | US7622105 Conjugation product of a cytokine selected from tumor necrosis factor and interferon gamma and a ligand of CD13 receptor; antitumor agents |
| 11/24/2009 | CA2507375C Use of rimexolone in the treatment of dry eye |
| 11/24/2009 | CA2493336C Composition for solubilization of paclitaxel and preparation method thereof |
| 11/24/2009 | CA2448030C Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid ester |
| 11/24/2009 | CA2445678C Paroxetine controlled release compositions |
| 11/24/2009 | CA2444880C Bifunctional-modified hydrogels |
| 11/24/2009 | CA2443774C Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation |
| 11/24/2009 | CA2423930C Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid |
| 11/24/2009 | CA2423836C Composition for the delivery of fentanyl |
| 11/24/2009 | CA2423384C New cross-linked derivatives of hyaluronic acid |
| 11/24/2009 | CA2419877C Storage stable tretinoin and 4-hydroxy anisole containing topical composition |
| 11/24/2009 | CA2413337C Bioadhesive compositions and methods of preparation and use |
| 11/24/2009 | CA2403831C Coating and binding agent for pharmaceutical formulations having improved storage stability |
| 11/24/2009 | CA2392050C Pharmaceutical formulations containing zolmitriptan |
| 11/24/2009 | CA2391660C Responsive polymeric hollow particles |
| 11/24/2009 | CA2383499C Drug delivery device |
| 11/24/2009 | CA2382651C Use of simple amino acids to form porous particles |
| 11/24/2009 | CA2381860C Matrix adhering to nasal mucosa |
| 11/24/2009 | CA2378379C Fast-release extrudates and process for their production, and preparations obtainable therefrom |
| 11/24/2009 | CA2362756C Method for producing film-type dosage forms |
| 11/24/2009 | CA2343120C Use of an anthracycline derivative for the treatment of a liver tumor |
| 11/24/2009 | CA2311109C Sugar-free hard coatings prepared from liquid mixtures of erythritol and sorbitol |
| 11/24/2009 | CA2264647C Fragmented polymeric hydrogels for adhesion prevention and their preparation |
| 11/19/2009 | WO2009140599A1 Treatment of metastatic tumors |
| 11/19/2009 | WO2009140588A1 Silk polymer-based adenosine release: therapeutic potential for epilepsy |
| 11/19/2009 | WO2009140510A1 Imaging methods and compositions comprising fluorescent dyes associated with viral components for nerve imaging |
| 11/19/2009 | WO2009140432A2 Micelles for intracellular delivery of therapeutic agents |
| 11/19/2009 | WO2009140421A2 Polymeric carrier |
| 11/19/2009 | WO2009140341A2 Atorvastatin compositions |
| 11/19/2009 | WO2009140162A1 Stable pharmaceutical formulations |
| 11/19/2009 | WO2009140131A2 Compliant composites for application of drug-eluting coatings to tissue surfaces |
| 11/19/2009 | WO2009139924A2 Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| 11/19/2009 | WO2009139905A2 Conjugates of a cholinesterase moiety and a polymer |
| 11/19/2009 | WO2009139411A1 Transdermal preparation containing palonosetron |
| 11/19/2009 | WO2009139213A1 Pharmaceutical composition for external application containing prochlorperazine |
| 11/19/2009 | WO2009138737A1 Topical composition of opioid compound for use in wound healing |
| 11/19/2009 | WO2009138477A2 Epithelial delivery |
| 11/19/2009 | WO2009138473A2 Intracellular antibody delivery |
| 11/19/2009 | WO2009138472A1 Amphiphilic block copolymers for nucleic acid delivery |
| 11/19/2009 | WO2009138396A2 Conjugates for the treatment of mesothelioma |
| 11/19/2009 | WO2009138042A1 A composition of glycoprotein hormone |
| 11/19/2009 | WO2009137964A1 Preparation of superparamagnetic composite microparticles from cyclodextrin |
| 11/19/2009 | WO2009137889A1 Polymer microgel beads |
| 11/19/2009 | WO2009137888A1 Polymer microgel beads and preparative method thereof |
| 11/19/2009 | WO2009121039A3 Administration of benzodiazepine compositions |
| 11/19/2009 | WO2009108005A3 Composition and method for screening active material used for the prevention and treatment of diabetes or obesity using senp2 and composition for the prevention and treatment of diabetes or obesity |
| 11/19/2009 | WO2009104939A3 Pharmaceutical preparation |
| 11/19/2009 | WO2009087665A3 Gastroretentive drug delivery system |
| 11/19/2009 | WO2009079910A8 An erythropoietin mimetic peptide derivatives and its pharmaceutical salt, the preparation and uses thereof |
| 11/19/2009 | WO2009077586A3 Methods and compositions for the preparation and use of toxin conjugates |
| 11/19/2009 | WO2009065947A3 Pharmaceutical composition containing a zeolite/algae or zeolite/emulsion combination for the treatment of aids |
| 11/19/2009 | WO2009055014A3 Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom |
| 11/19/2009 | WO2009046220A3 Lipopeptides for delivery of nucleic acids |
| 11/19/2009 | WO2009045539A3 Peg-corticosteroid conjugates |
| 11/19/2009 | WO2009040843A3 Preparation of micro or nano systems detectable in biological environments based on inorganic oxides with controlled porosity for carrying biologically active or activable substances |
| 11/19/2009 | WO2009010877A3 Conjugate purification |
| 11/19/2009 | WO2009007341A3 Topical composition containing adapalene for the treatment of keratini zation disorders |
| 11/19/2009 | WO2008139457A3 Ph-dependent drug targeting |
| 11/19/2009 | WO2008131940A3 Combination of immunological agent and sensitizing agent for the treatment of cancer |
| 11/19/2009 | WO2008128049A3 Tetrahydrobiopterin compositions and methods of measuring |
| 11/19/2009 | WO2008112286A3 De novo synthesis of conjugates |
| 11/19/2009 | WO2008093166A3 Targeting macrophages through sialoadhesin |
| 11/19/2009 | WO2006054240A3 Ultrasound contrast agents for molecular imaging |
| 11/19/2009 | US20090286887 Stabilisation of colorants in cosmetic and dermatological preparations |
| 11/19/2009 | US20090286886 Resorbable polymer compositions for use in medicine, dentistry, and surgery |